6 June, 2022

Fausto Pinto, director of the Faculty of Medicine of Lisbon, announced a week ago his candidacy to become a member of the Portuguese Medical Association. There is probably no doctor with better relations with pharmaceutical companies: since 2018, his Association for Research and Development of the Faculty of Medicine has received more than 4 million euros in sponsorship and support for studies. In the lead is Gilead, with more than 1.5 million euros, a substantial part for studies (never seen before) on the effects of the controversial antiviral remdesivir.